Oly Katari

Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth Liposomes

Dasharath Chaudhari, Oly Katari, Rohan Ghadi et al. · ACS Biomaterials Science & Engineering · 2022 · 28 citations

Application of Design of Experiments® Approach-Driven Artificial Intelligence and Machine Learning for Systematic Optimization of Reverse Phase High Performance Liquid Chromatography Method to Analyze Simultaneously Two Drugs (Cyclosporin A and Etodolac) in Solution, Human Plasma, Nanocapsules, and Emulsions

Syed Nazrin Ruhina Rahman, Oly Katari, Datta Maroti Pawde et al. · AAPS PharmSciTech · 2021 · 25 citations

Engineering, Machine Learning, Medicine +10

Systematic Optimization, In Vitro Drug Release, and Preliminary Nonclinical Toxicity Assessment of Nonphospholipid-Based Topical Ophthalmic Emulsions Containing 0.05 or 0.1% w/w Cyclosporin A for Dry-Eye Syndrome Management

Syed Nazrin Ruhina Rahman, Datta Maroti Pawde, Oly Katari et al. · AAPS PharmSciTech · 2019 · 23 citations · Full text

Vitro Drug Release, Dry-eye Syndrome Management, Ocular Disease +9

Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management

Ashwin Abhang, Oly Katari, Rohan Ghadi et al. · Drug Delivery and Translational Research · 2023 · 17 citations

Nanoparticles, Nanomedicine, Oncology +12

Enhancing oral bioavailability of dasatinib via supersaturable SNEDDS: Investigation of precipitation inhibition and IVIVC through in-vitro lipolysis-permeation model

Dharshini Mageshvaran, Sheetal Yadav, Vivek R. Yadav et al. · International Journal of Pharmaceutics · 2024 · 12 citations